clinical trial · NCT05167825
A Study of Macitentan in Japanese Pediatric Participants With Pulmonary Arterial Hypertension
Janssen Pharmaceutical K.K.·phase3·completed·n = 7
Pulmonary Arterial HypertensionMacitentan
brief summary
The purpose of this study is to evaluate the effect of macitentan on hemodynamic measures at Week 24 in pediatric populations.
started
Nov 14, 2022
primary completion
Aug 23, 2024
completion
Mar 5, 2025
last updated
May 7, 2026
official title
A Multicenter, Open-label, Phase III Study to Assess the Efficacy, Safety, and Pharmacokinetics of Macitentan in Japanese Pediatric Patients (>=3 Months to <15 Years) With Pulmonary Arterial Hypertension
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol